Immutep (IMMP) Change in Receivables (2016 - 2024)
Immutep (IMMP) posted Change in Receivables of $396577.9 for Q2 2024, down 97.98% on a QoQ basis from $19.6 million in Q4 2023, and up 136.91% year-over-year from $167398.0 in Q3 2023.
Immutep (IMMP) Change in Receivables (2016 - 2024) Analysis & Trends
Immutep's Change in Receivables history runs 5 years deep, the most recent figure standing at $396577.9 for Q2 2024.
- Quarterly Change in Receivables rose 136.91% year-over-year to $396577.9 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $20.2 million (up 1584.08% YoY) and the FY2024 annual result came in at $396577.9, up 136.91% from the prior year.
- Change in Receivables was $396577.9 for Q2 2024 at Immutep, down from $19.6 million in the prior quarter.
- Across five years, Change in Receivables topped out at $19.6 million in Q4 2023 and bottomed at -$1.1 million in Q2 2023.
- A 3-year average of $5.0 million and a median of $821080.8 in 2020 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2020 — Change in Receivables soared 200.91% — and 2024, when it soared 136.91%.
- Immutep's Change in Receivables stood at $1.2 million in 2020, then surged by 1472.63% to $19.6 million in 2023, then plunged by 97.98% to $396577.9 in 2024.
- Business Quant data shows IMMP's Change in Receivables at $396577.9 in Q2 2024, $19.6 million in Q4 2023, and -$1.1 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immutep | 567.77 Mn | 567.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 396,577.87 |
| Jun 30, 2024 | 396,577.87 |
| Dec 31, 2023 | 19.59 Mn |
| Dec 31, 2023 | 19.59 Mn |
| Jun 30, 2023 | -1.07 Mn |
| Jun 30, 2023 | -1.07 Mn |
| Jun 30, 2020 | 1.25 Mn |
| Jun 30, 2020 | 1.25 Mn |
| Jun 30, 2019 | -1.23 Mn |
| Jun 30, 2019 | -1.23 Mn |
| Jun 30, 2016 | -294,889.21 |
| Jun 30, 2016 | -294,889.21 |